MedPath

RIVA-LEVETIRACETAM

RIVA-LEVETIRACETAM

Dormant
DIN Number

02482282

Drug Class

Human

Market Date

Apr 12, 2019

Company
HC

laboratoire riva inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02482282
AIG Number0148843002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX14 LEVETIRACETAM
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

LEVETIRACETAMActive
Strength: 500 MG
Monograph: LEVETIRACETAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.